[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
June 15, 2005

Pharmacotherapy for Adolescent ObesityA Weighty Issue

Author Affiliations
 

Author Affiliation: Student Health and Wellness Center, Johns Hopkins University, Baltimore, Md.

JAMA. 2005;293(23):2932-2934. doi:10.1001/jama.293.23.2932

Until public health efforts to prevent child and adolescent obesity are developed and successfully implemented on a broad scale, physicians are likely to encounter significant numbers of obese adolescents for the foreseeable future. Many of these young people display features associated with the development of type 2 diabetes and cardiovascular disease, and some experience social stigma and other psychosocial morbidity. Research has shown that obese adolescents are likely to become obese adults,1 yet changing the trajectory of obesity in this age group remains an elusive goal. Hence, appropriate management of this chronic health condition is a pressing but daunting task for physicians.

First Page Preview View Large
First page PDF preview
First page PDF preview
×